HELLP syndrome Flashcards
How is HELLP syndrome defined?
HELLP syndrome is defined by a series of laboratory dysfunction including:
-Hemolysis (see schistocytes on peripheral smear, also see increased LDH >600 and indirect bilirubin)
-Elevated Liver enzymes - >70, twice the upper limit of normal
Low platelet - <100
***This is the Tennessee Classification
What are maternal risks from HELLP syndrome?
- DIC in 21%
- Abruption in 16%
- Renal failure in 8%
- Stroke
- Venothromboembolism
- Need for c-section
What are fetal risks from HELLP syndrome?
Prematurity, abruption and the risks associated with that.
What would make you suspect a subcapsular hematoma?
- RUQ pain (occurs in 90%) and abnormal LFT test
- Nausea/vomiting (occurs in 50%)
If a subcapsular hematoma is identified, how will you manage the patient?
- Obtain CT/MRI
- Assess hemodynamic and coagulation parameters
- Do not delay delivery
What are the risks of a subcapsular hematoma?
- Liver rupture and failure
- Hemorrhage
- Maternal death (mortality occurs in 18-86% of patient with liver rupture)
***Care with patient transport to avoid rupture
How do you manage a patient with a ruptured subcapsular hematoma?
- Call for massive transfusion protocol
- STAT anesthesia and trauma consultation
- Delivery via cesarean section, avoid further trauma to liver
- Care with patient transport to avoid further damage
- Trauma surgery consultation for peritoneal packing/hemostatic mesh
- PT/PTT/Fibrinogen/CBC
- Transfuse as needed
How do you counsel patient about recurrence risks following a pregnancy complicated by HELLP syndrome?
Recurrence risk is 5%
What is atypical HELLP and how often is it seen?
Seen in 15% and lacks HTN or proteinuria
What laboratory findings in HELLP suggest an increase in maternal mortality?
AST greater than 2000
LDH more than 3000
Obtain blood work every 12 hours in patients with HELLP
HUS verses Atypical HUS
HUS Hemolysis Uremia Thrombocytopenia Syndrome Caused by shiga toxin from E. Coli H7:0157
Atypical HUS can be caused by HELLP.
Hallmark is abnormal complement activation.
Treat with Soliris (anti C5 antibody - eculizumab)
TTP
Thrombotic
Thrombocytopenic
Purpura
Hallmark - hemolysis, urea , thrombocytopenia, fever, altered mental state
See deficiency in ADAMS13
Treat with plasmaphoresis (plasma exchange)
Acute Fatty Liver
1 in 10,000 Increase risk with LCHAD deficiency \+/- hemolysis \+/- thrombocytopenia Increased bilirubin and AST and AMMONIA Treatment is DELIVERY and supportive care Lactulose to bring down ammonia